Skip to main content

Migraine clinical trials at UCSD

3 in progress, 0 open to eligible people

Showing trials for
  • Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment

    Sorry, not yet accepting patients

    This pilot crossover study will evaluate 3 different potencies of inhaled cannabis (2.5%, 5%, and 10%) and inhaled placebo cannabis for the acute treatment of migraine.

    La Jolla, California

  • Efficacy of Inhaled Cannabis for Acute Migraine Treatment

    Sorry, in progress, not accepting new patients

    This crossover study will evaluate 3 different treatments of vaporized cannabis (THC, THC/CBD mix, and CBD) and vaporized placebo cannabis for the acute treatment of migraine.

    La Jolla, California

  • Safety of Nerivio in Pregnant Women With Migraine

    Sorry, not currently recruiting here

    This is a retrospective controlled survey study to assess the safety of treating migraine with Nerivio during pregnancy and 3 months postpartum. The study will compare migraine and pregnancy-related health and baby health between women with migraine who treated migraine attacks during pregnancy with Nerivio (Nerivio group), to women with migraine who did not treat migraine attacks during pregnancy with Nerivio (control group). Nerivio group participants will be recruited from Theranica's user base. Control group participants will be recruited by health care providers, including headache specialists and OBGYNs (study co-investigators). The study is based on an e-Survey including an e-eligibility questionnaire, an e-ICF ande-Questionnaire. Participants will be compensated for their time.

    San Diego, California and other locations

Our lead scientists for Migraine research studies include .

Last updated: